Crossmark

Beyond Sidedness: DNA Methylation as a Biomarker to Refine Anti-EGFR Treatment Selection in RAS/BRAF Wild-type Metastatic Colorectal Cancer

Published Online: 2026-06-04

Authors

Sagawa, Tamotsu https://orcid.org/0000-0002-1994-4795
Nagashima, Hiroyuki

Fujikawa, Koshi
License Information

Text and Data Mining valid from 2026-06-04

Version of Record valid from 2026-06-04
More Information

Article History

Received: 10 April 2026

Accepted: 30 May 2026

First Online: 4 June 2026

Declarations

:

: The authors declare no competing interests.

Document is current